SCHEMBL19746550

SCHEMBL19746550

CCCCOCCOc1ccc(OC(=O)C2=Cc3ccccc3N(CCCC)CCC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 10/20 0.45
CCR2 P41597 2/20 0.41
CCR7 P32248 1/20 0.41
RARB P10826 1/20 0.40
CCR3 P51677 1/20 0.39
CCR4 P51679 1/20 0.39
MAPT P10636 3/20 0.39
TSHR P16473 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17870854 0.79 CCR5 (0.58) CCR5CCR2CCR7RARBCCR3
SCHEMBL17870855 0.79 CCR5 (0.58) CCR5CCR2CCR7RARBCCR3
SCHEMBL3459500 0.78 CCR5 (0.62) CCR5CCR2CCR7RARBCCR3
SCHEMBL3459503 0.78 CCR5 (0.62) CCR5CCR2CCR7RARBCCR3
SCHEMBL19747069 0.78 MEN1 (0.44) MAPTALDH1A1POLBKDM4EMEN1
SCHEMBL17870853 0.78 MEN1 (0.44) MAPTALDH1A1POLBKDM4EMEN1
SCHEMBL22546122 0.76 CCR5 (0.56) CCR5CCR2CCR7RARBCCR3
SCHEMBL3458877 0.75 CCR5 (0.61) CCR5CCR2CCR7RARBCCR3
SCHEMBL3458880 0.75 CCR5 (0.61) CCR5CCR2CCR7RARBCCR3
SCHEMBL3460407 0.75 CCR5 (0.62) CCR5CCR2CCR7RARBCCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3471718-A1 PURIFIED CENICRIVIROC AND PURIFIED INTERMEDIATES FOR MAKING CENICRIVIROC Tobira Therapeutics, Inc. (US) 2019-04-24 EP claimed
WO-2017223155-A1 PURIFIED CENICRIVIROC AND PURIFIED INTERMEDIATES FOR MAKING CENICRIVIROC TOBIRA THERAPEUTICS, INC. (US) 2017-12-28 WO claimed